Renal Denervation Catheters - Medical Devices Pipeline Assessment, 2018

  • ID: 4580445
  • Report
  • 112 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc
  • CryoMedix, LLC.
  • Johns Hopkins University
  • MicroPort Scientific Corp
  • ReCor Medical Inc
  • St. Jude Medical LLC
  • MORE
Renal Denervation Catheters - Medical Devices Pipeline Assessment, 2018

Summary

The Medical Devices sector report, “Renal Denervation Catheters - Medical Devices Pipeline Assessment, 2018" provides an overview of Renal Denervation Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Renal Denervation Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Renal Denervation Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Renal Denervation Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Renal Denervation Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc
  • CryoMedix, LLC.
  • Johns Hopkins University
  • MicroPort Scientific Corp
  • ReCor Medical Inc
  • St. Jude Medical LLC
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Renal Denervation Catheters Overview

3 Products under Development
3.1 Renal Denervation Catheters - Pipeline Products by Stage of Development
3.2 Renal Denervation Catheters - Pipeline Products by Segment
3.3 Renal Denervation Catheters - Pipeline Products by Territory
3.4 Renal Denervation Catheters - Pipeline Products by Regulatory Path
3.5 Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
3.6 Renal Denervation Catheters - Ongoing Clinical Trials

4 Renal Denervation Catheters - Pipeline Products under Development by Companies
4.1 Renal Denervation Catheters Companies - Pipeline Products by Stage of Development
4.2 Renal Denervation Catheters - Pipeline Products by Stage of Development

5 Renal Denervation Catheters Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Boston Scientific Corp Company Overview
5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 CardioSonic Ltd. Company Overview
5.3.1 CardioSonic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.4 CryoMedix, LLC. Company Overview
5.4.1 CryoMedix, LLC. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Handok Inc Company Overview
5.5.1 Handok Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Handok-Kalos Medical Company Overview
5.6.1 Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
5.7 Johns Hopkins University Company Overview
5.7.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.8 Kona Medical Inc Company Overview
5.8.1 Kona Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Lepu Medical Technology (Beijing) Co Ltd Company Overview
5.9.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.10 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.10.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 Medtronic plc Company Overview
5.11.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.12 MicroPort Scientific Corp Company Overview
5.12.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.13 Northwind Medical Inc Company Overview
5.13.1 Northwind Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Pavmed Inc Company Overview
5.14.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 ReCor Medical Inc Company Overview
5.15.1 ReCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Renal Dynamics, LLC Company Overview
5.16.1 Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 Sound Interventions, Inc. Company Overview
5.17.1 Sound Interventions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.18 St. Jude Medical LLC Company Overview
5.18.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.19 Suzhou SyMap Medical Ltd Company Overview
5.19.1 Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 Symple Surgical Inc. Company Overview
5.20.1 Symple Surgical Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.21 Terumo Corp Company Overview
5.21.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
5.22 Trinity College Dublin Company Overview
5.22.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
5.23 University of Sydney Company Overview
5.23.1 University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
5.24 Verve Medical, Inc. Company Overview
5.24.1 Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6 Renal Denervation Catheters- Recent Developments
6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.2 May 23, 2018: New Medtronic Data Show Significant Blood Pressure Lowering Effect of Renal Denervation in Patients Taking Anti-Hypertensive Medication
6.3 May 23, 2018: ReCor Medical Announces RADIANCE-HTN SOLO Hypertension Study Meets Primary Efficacy Endpoint, Pivotal Study Submission, and New Principal Investigator
6.4 May 18, 2018: ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris
6.5 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow
6.6 May 09, 2018: Upmc Pinnacle Participating In Groundbreaking Trial To Help Lower Blood Pressure
6.7 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.8 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.9 Apr 25, 2018: Xianjian Technology Receives the Most Attention from Institutional Investors
6.10 Apr 09, 2018: Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension
6.11 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.12 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017
6.13 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.14 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.15 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers
6.16 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.17 Jan 07, 2018: LifeTech Scientific and Ally Bridge Group Form China-Global Medtech Investment and Operating Partnership
6.18 Jan 05, 2018: ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study
6.19 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.20 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems
6.21 Nov 24, 2017: MicroPort EP's Contact Force Sensing RF Ablation Catheter Gains CFDA Green-Path
6.22 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.23 Nov 15, 2017: PAVmed Reports Third Quarter 2017 Financial Results
6.24 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.25 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.26 Oct 30, 2017: ReCor Medical Announces 1000th Enrollment and 150th Randomization in RADIANCE-HTN Hypertension Study
6.27 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
6.28 Oct 16, 2017: The Essex Cardiothoracic Centre team trial novel high blood pressure treatment that could revolutionize care
6.29 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.30 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
6.31 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California
6.32 Aug 31, 2017: Westmead inventors win $1.39m to bankroll novel medical device
6.33 Aug 30, 2017: Our inventors win $3m to bankroll novel medical devices
6.34 Aug 28, 2017: Medtronic Plans for Renal Denervation Pivotal Trial After New Study Shows Significant Blood Pressure Reductions
6.35 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.36 Aug 14, 2017: PAVmed Reports Second Quarter 2017 Financial Results
6.37 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.38 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Renal Denervation Catheters - Pipeline Products by Stage of Development
Table 2: Renal Denervation Catheters - Pipeline Products by Segment
Table 3: Renal Denervation Catheters - Pipeline Products by Territory
Table 4: Renal Denervation Catheters - Pipeline Products by Regulatory Path
Table 5: Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
Table 6: Renal Denervation Catheters - Ongoing Clinical Trials
Table 7: Renal Denervation Catheters Companies - Pipeline Products by Stage of Development
Table 8: Renal Denervation Catheters - Pipeline Products by Stage of Development
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Chemical RDN System - Product Status
Table 11: Chemical RDN System - Product Description
Table 12: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Vessix Renal Denervation System - Product Status
Table 14: Vessix Renal Denervation System - Product Description
Table 15: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 16: Vessix Renal Denervation System - A Boston Scientific Clinical Trial of Renal Denervation Using the Vessix Reduce Catheter and Vessix Generator for the Treatment of Hypertension (REINFORCE)
Table 17: Vessix Renal Denervation System - Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Table 18: Vessix Renal Denervation System - Endovascular Renal Sympathetic Denervation Using the Boston Scientific Vessix V2 renal Denervation System to Improve Heart Failure
Table 19: Vessix Renal Denervation System - Renal Sympathetic Denervation to Suppress Tachyarrhythmias in ICD Recipients
Table 20: Vessix Renal Denervation System - The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients with Severe Debilitating Pain
Table 21: CardioSonic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Next Generation TIVUS System - Product Status
Table 23: Next Generation TIVUS System - Product Description
Table 24: CryoMedix, LLC. Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Catheter Based Cryoablation System - Product Status
Table 26: Catheter Based Cryoablation System - Product Description
Table 27: Handok Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: 2nd Gen Renal Denervation System - Product Status
Table 29: 2nd Gen Renal Denervation System - Product Description
Table 30: 3rd Gen Renal Denervation System - Product Status
Table 31: 3rd Gen Renal Denervation System - Product Description
Table 32: Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 33: DENEX - Product Status
Table 34: DENEX - Product Description
Table 35: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Flexible Renal Denervation Ablation Device - Product Status
Table 37: Flexible Renal Denervation Ablation Device - Product Description
Table 38: Kona Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Surround Sound System - Product Status
Table 40: Surround Sound System - Product Description
Table 41: Kona Medical Inc - Ongoing Clinical Trials Overview
Table 42: Surround Sound System - Phase II Randomized Sham Controlled Study of Renal Denervation for Untreated Stage I and II Hypertension: Wave VI Feasibility Study
Table 43: Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Renal Denervation System - Product Status
Table 45: Renal Denervation System - Product Description
Table 46: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Renal Denervation Catheter - Product Status
Table 48: Renal Denervation Catheter - Product Description
Table 49: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Symplicity Renal Denervation System - Product Status
Table 51: Symplicity Renal Denervation System - Product Description
Table 52: Symplicity Spyral Renal Denervation Catheter - Product Status
Table 53: Symplicity Spyral Renal Denervation Catheter - Product Description
Table 54: Medtronic plc - Ongoing Clinical Trials Overview
Table 55: Symplicity Renal Denervation System - A Prospective, Multicenter, Randomized, Open-label, Feasibility, Safety and Efficacy Study of Renal Denervation in Patients with Chronic Heart Failure (CHF)
Table 56: Symplicity Renal Denervation System - Effects of Catheter Based Renal Sympathetic Denervation on Resistant Hypertension in End Stage Renal Disease in Korea
Table 57: Symplicity Renal Denervation System - Global Prospective Registry for Sympathetic Renal Denervation in Selected Indications Through 3 Years Registry
Table 58: Symplicity Renal Denervation System - Impact of Renal Artery Denervation in Patients with Chronic Heart Failure Compared with Sham Procedure
Table 59: Symplicity Renal Denervation System - Prairie Renal Denervation Study
Table 60: Symplicity Renal Denervation System - Renal Denervation in Treatment Resistant Hypertension
Table 61: Symplicity Renal Denervation System - Renal Sympathetic Denervation Restores Autonomic Imbalance and Prevents Atrial Fibrillation in Patients with Hypertensive Heart Disease: A Pilot Study
Table 62: Symplicity Renal Denervation System - Understanding the Mechanisms of Progressive Decrease In Blood Pressure After Renal Nerve Ablation
Table 63: Symplicity Spyral Renal Denervation Catheter - A Randomized Comparison of Ultrasound Based Versus Radiofrequency Based Catheter Ablation Techniques in Patients with Therapy Resistant Arterial Hypertension with Large Renal Arteries
Table 64: Symplicity Spyral Renal Denervation Catheter - Combined Treatment with Percutaneous Coronary Intervention and Renal Denervation in Hypertensive Patients with Acute Coronary Syndromes
Table 65: Symplicity Spyral Renal Denervation Catheter - Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension in the Absence of Antihypertensive Medications (SPYRAL HTN-OFF MED)
Table 66: Symplicity Spyral Renal Denervation Catheter - Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension on Standard Medical Therapy: SPYRAL HTN-ON MED
Table 67: Symplicity Spyral Renal Denervation Catheter - Pivotal Study for the Assessment of Safety and Efficacy of Symplicity Spyral Renal Denervation System in Subjects with Hypertension
Table 68: Symplicity Spyral Renal Denervation Catheter - Renal Nerve Denervation in Patients with Hypertension and Paroxysmal and Persistent Atrial Fibrillation
Table 69: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 70: FlashPoint Renal Artery RF Ablation Catheter - Product Status
Table 71: FlashPoint Renal Artery RF Ablation Catheter - Product Description
Table 72: Northwind Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Guidewire Based Catheter - Product Status
Table 74: Guidewire Based Catheter - Product Description
Table 75: Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Caldus - Renal Denervation - Product Status
Table 77: Caldus - Renal Denervation - Product Description
Table 78: ReCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 79: PARADISE Renal Denervation System - Product Status
Table 80: PARADISE Renal Denervation System - Product Description
Table 81: ReCor Medical Inc - Ongoing Clinical Trials Overview
Table 82: PARADISE Renal Denervation System - A Clinical Study of the Ultrasound Renal Denervation System in Patients with Resistant Hypertension
Table 83: PARADISE Renal Denervation System - A Randomized Comparison of Ultrasound Based Versus Radiofrequency Based Catheter Ablation Techniques in Patients with Therapy Resistant Arterial Hypertension with Large Renal Arteries
Table 84: PARADISE Renal Denervation System - Renal Denervation by UltraSound Transcatheter Emission

List of Figures
Figure 1: Renal Denervation Catheters - Pipeline Products by Stage of Development
Figure 2: Renal Denervation Catheters - Pipeline Products by Segment
Figure 3: Renal Denervation Catheters - Pipeline Products by Territory
Figure 4: Renal Denervation Catheters - Pipeline Products by Regulatory Path
Figure 5: Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
Figure 6: Renal Denervation Catheters - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Vascular Inc
  • Boston Scientific Corp
  • CardioSonic Ltd.
  • CryoMedix, LLC.
  • Handok Inc
  • Handok-Kalos Medical
  • Johns Hopkins University
  • Kona Medical Inc
  • Lepu Medical Technology (Beijing) Co Ltd
  • Lifetech Scientific (Shenzhen) Co Ltd
  • Medtronic plc
  • MicroPort Scientific Corp
  • Northwind Medical Inc
  • Pavmed Inc
  • ReCor Medical Inc
  • Renal Dynamics, LLC
  • Sound Interventions, Inc.
  • St. Jude Medical LLC
  • Suzhou SyMap Medical Ltd
  • Symple Surgical Inc.
  • Terumo Corp
  • Trinity College Dublin
  • University of Sydney
  • Verve Medical, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll